Cargando…
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
BACKGROUND: The aims of this study were (1) to clarify the impact of tertiary lymphoid structure (TLS) status on the outcome and immunogenomic profile of human clear cell renal cell carcinoma (ccRCC) and (2) to determine phenotypic differences in TLSs between different types of genitourinary cancer,...
Autores principales: | Masuda, Tsukasa, Tanaka, Nobuyuki, Takamatsu, Kimiharu, Hakozaki, Kyohei, Takahashi, Ryohei, Anno, Tadatsugu, Kufukihara, Ryohei, Shojo, Kazunori, Mikami, Shuji, Shinojima, Toshiaki, Kakimi, Kazuhiro, Tsunoda, Tatsuhiko, Aimono, Eriko, Nishihara, Hiroshi, Mizuno, Ryuichi, Oya, Mototsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938705/ https://www.ncbi.nlm.nih.gov/pubmed/35314433 http://dx.doi.org/10.1136/jitc-2021-003883 |
Ejemplares similares
-
Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
por: Takamatsu, Kimiharu, et al.
Publicado: (2021) -
Can urologists introduce the concept of “oligometastasis” for metastatic bladder cancer after total cystectomy?
por: Ogihara, Koichiro, et al.
Publicado: (2017) -
Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report
por: Hongo, Hiroshi, et al.
Publicado: (2020) -
A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation
por: Kosaka, Takeo, et al.
Publicado: (2019) -
Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Daimon, Tatsuaki, et al.
Publicado: (2021)